A1RG34:BVMF
Argenx Se Bdr
187,38 BRL
0,00%
(0,00) 1D
6-окт., 14:05:54 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Mkt. cap
42,32 млд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 BRL
52-wk low
143,22 BRL
Shares outstanding
62,89 млн
No. of employees
2 миң
Mkt. cap
42,32 млд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 BRL
52-wk low
143,22 BRL
Shares outstanding
62,89 млн
No. of employees
2 миң
News stories
From web sources and news partners
European Biotechnology Magazine
·
7 мүнөт мурун
Argenx halts Phase 3 Sjögren’s trial, sending shares tumbling
Yahoo Finance
·
50 мүнөт мурун
Argenx to Discontinue Late-Stage Sjogren's Disease Trial; Shares Down Pre-Bell
TipRanks
·
59 мүнөт мурун
Argenx Stock Sinks as Key Drug Trial Collapses
Yahoo Finance
·
1 саат мурун
Halozyme Therapeutics (HALO) Expands Argenx Deal, Is It Still 27% Below Fair Value?
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr